Amylin Pharmaceuticals, Inc.

369 articles with Amylin Pharmaceuticals, Inc.

• Amylin Pharmaceuticals, Inc. Release: BYDUREON™ Was Associated With Significant and Sustained Glycemic Control at Four Years

  6/11/2012

• Amylin Pharmaceuticals, Inc. Release: BYDUREON™ Improved A1C, Fasting Glucose, Pulse Pressure and Weight Regardless of Baseline Body Weight in Patients With Type 2 Diabetes

  6/11/2012

• FDA Seeks Data on Delivery Method for Amylin Pharmaceuticals, Inc. Drug

  6/7/2012

• Amylin Pharmaceuticals, Inc. Preps for 2nd Round After Bids Boost Appeal

  6/6/2012

• AstraZeneca PLC Bids $4 Billion for Diabetes Specialist Amylin Pharmaceuticals, Inc.

  6/5/2012

• Amylin Pharmaceuticals, Inc. to Present Data on BYDUREON™, BYETTA®and SYMLIN® at the American Diabetes Association 2012 Meeting

  6/5/2012

• Amylin Pharmaceuticals, Inc. to Present at Jefferies and Co. 2012 Global Healthcare Conference and Goldman, Sachs & Co. 33rd Annual Global Healthcare Conference

  5/30/2012

• Amylin Pharmaceuticals, Inc. Said to Draw First-Round Bids From Merck & Co., Inc., Sanofi (France)

  5/29/2012

• Amylin Pharmaceuticals, Inc. Said to Attract Interest From Pfizer Inc., AstraZeneca PLC, Sanofi (France)

  5/15/2012

• Amylin Pharmaceuticals, Inc. Executive, Marcea Bland Lloyd, Receives Athena San Diego's 2012 Pinnacle Award

  5/8/2012

• Icahn Drops Suit After Making Nice With Amylin Pharmaceuticals, Inc. CEO

  4/26/2012

• Icahn and Amylin Pharmaceuticals, Inc. Have May 10 Hearing for Proxy War

  4/25/2012

• Icahn Sues Amylin Pharmaceuticals, Inc. in Shake-up Try

  4/10/2012

• Icahn Lashes Amylin Pharmaceuticals, Inc. Board, Urges Sale of Company

  4/5/2012

• Amylin Pharmaceuticals, Inc. Completes Biologics License Application for Metreleptin to Treat Diabetes and/or Hypertriglyceridemia in Patients With Rare Forms of Lipodystrophy

  4/3/2012

• Amylin Pharmaceuticals, Inc. Said to Have Spurned $3.5 Billion Bristol-Myers Squibb Company Bid

  3/28/2012

• Amylin Pharmaceuticals, Inc., Eli Lilly and Company Receive EU OK for New Byetta Use

  3/26/2012

• Amylin Pharmaceuticals, Inc. to Ring The NASDAQ Stock Market Opening Bell

  3/26/2012

• Amylin Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

  3/9/2012

• Amylin Pharmaceuticals, Inc. to Present at Barclays Capital Global Healthcare Conference

  3/8/2012